These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12874614)

  • 41. QT-interval parameters are increased in systemic lupus erythematosus patients.
    Cardoso CR; Sales MA; Papi JA; Salles GF
    Lupus; 2005; 14(10):846-52. PubMed ID: 16302681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. QT dispersion in patients with different etiologies of left ventricular hypertrophy: the significance of QT dispersion in endurance athletes.
    Zoghi M; Gürgün C; Yavuzgil O; Akilli A; Türkoglu C; Kültürsay H; Akin M
    Int J Cardiol; 2002 Aug; 84(2-3):153-9. PubMed ID: 12127367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrocardiographic prediction of left ventricular geometric patterns in patients with essential hypertension.
    Aktoz M; Erdogan O; Altun A
    Int J Cardiol; 2007 Sep; 120(3):344-50. PubMed ID: 17169449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ethnic and gender differences in electrocardiographic QT length and QT dispersion in hypertensive subjects.
    Chapman N; Mayet J; Ozkor M; Foale R; Thom S; Poulter N
    J Hum Hypertens; 2000 Jun; 14(6):403-5. PubMed ID: 10878705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QT dispersion in essential hypertension.
    Clarkson PB; Naas AA; McMahon A; MacLeod C; Struthers AD; MacDonald TM
    QJM; 1995 May; 88(5):327-32. PubMed ID: 7796087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk assessment of echocardiographic left ventricular hypertrophy with electrocardiography, body mass index and blood pressure.
    Varis JP; Puukka PJ; Karanko HM; Jula AM
    Blood Press; 2014 Feb; 23(1):39-46. PubMed ID: 23772751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
    Oikarinen L; Nieminen MS; Viitasalo M; Toivonen L; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Hypertension; 2004 May; 43(5):1029-34. PubMed ID: 15037560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of QT dispersion in athletic and hypertensive left ventricular hypertrophy.
    Lonati LM; Magnaghi G; Bizzi C; Leonetti G
    Ann Noninvasive Electrocardiol; 2004 Jul; 9(3):252-6. PubMed ID: 15245341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QT dispersion in elderly athletes with left ventricular hypertrophy.
    Galetta F; Franzoni F; Santoro G; Prattichizzo F; Femia FR; Pastine F; Pentimone F
    Int J Sports Med; 2003 May; 24(4):233-7. PubMed ID: 12784163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
    Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between stage of left ventricular diastolic dysfunction and QT dispersion.
    Gunduz H; Akdemir R; Binak E; Tamer A; Uyan C
    Acta Cardiol; 2003 Aug; 58(4):303-8. PubMed ID: 12948035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of relative wall thickness on electrocardiographic voltage measures in left ventricular hypertrophy: a novel factor contributing to poor diagnostic accuracy.
    Ye N; Sun GZ; Zhou Y; Wu SJ; Sun YX
    Postgrad Med; 2020 Mar; 132(2):141-147. PubMed ID: 31900004
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy.
    Bombelli M; Vanoli J; Cuspidi C; Dell'Oro R; Facchetti R; Mancia G; Grassi G
    J Clin Hypertens (Greenwich); 2023 Apr; 25(4):343-349. PubMed ID: 36824023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between left ventricular mass and blood pressure in treated hypertension.
    Missault LH; De Buyzere ML; De Bacquer DD; Duprez DD; Clement DL
    J Hum Hypertens; 2002 Jan; 16(1):61-6. PubMed ID: 11840231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved electrocardiographic diagnosis of left ventricular hypertrophy.
    Schillaci G; Verdecchia P; Borgioni C; Ciucci A; Guerrieri M; Zampi I; Battistelli M; Bartoccini C; Porcellati C
    Am J Cardiol; 1994 Oct; 74(7):714-9. PubMed ID: 7942532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
    J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation between age, ventricular arrhythmia, left ventricular hypertrophy and QT dispersion in patients with essential hypertension.
    Saadeh AM
    Acta Cardiol; 2004 Jun; 59(3):249-53. PubMed ID: 15255455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.